CLSA has maintains outperform on Torrent Pharma, raises target price to Rs 2,050
CLSA has maintained outperform rating on Torrent Pharmaceuticals and raised target price to Rs 2,050 from Rs 1,950. The stock ended down 5.6% at Rs 1,913.25 on Tuesday while the BSE Sensex closed 1…
